These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33440429)

  • 41. Clinical trial site identification practices and the use of electronic health records in feasibility evaluations: An interview study in the Nordic countries.
    Laaksonen N; Bengtström M; Axelin A; Blomster J; Scheinin M; Huupponen R
    Clin Trials; 2021 Dec; 18(6):724-731. PubMed ID: 34431408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrating clinical research with the Healthcare Enterprise: from the RE-USE project to the EHR4CR platform.
    El Fadly A; Rance B; Lucas N; Mead C; Chatellier G; Lastic PY; Jaulent MC; Daniel C
    J Biomed Inform; 2011 Dec; 44 Suppl 1():S94-S102. PubMed ID: 21888989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Real-Time Automated Patient Screening System for Clinical Trials Eligibility in an Emergency Department: Design and Evaluation.
    Ni Y; Bermudez M; Kennebeck S; Liddy-Hicks S; Dexheimer J
    JMIR Med Inform; 2019 Jul; 7(3):e14185. PubMed ID: 31342909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Business analysis for a sustainable, multi-stakeholder ecosystem for leveraging the Electronic Health Records for Clinical Research (EHR4CR) platform in Europe.
    Dupont D; Beresniak A; Sundgren M; Schmidt A; Ainsworth J; Coorevits P; Kalra D; Dewispelaere M; De Moor G
    Int J Med Inform; 2017 Jan; 97():341-352. PubMed ID: 27919393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The correlation between the number of eligible patients in routine clinical practice and the low recruitment level in clinical trials: a retrospective study using electronic medical records.
    Sumi E; Teramukai S; Yamamoto K; Satoh M; Yamanaka K; Yokode M
    Trials; 2013 Dec; 14():426. PubMed ID: 24326039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Success and failure factors of patient recruitment for industry-sponsored clinical trials and the role of the electronic health records-a qualitative interview study in the Nordic countries.
    Laaksonen N; Bengtström M; Axelin A; Blomster J; Scheinin M; Huupponen R
    Trials; 2022 May; 23(1):385. PubMed ID: 35550003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computable Eligibility Criteria through Ontology-driven Data Access: A Case Study of Hepatitis C Virus Trials.
    Zhang H; He Z; He X; Guo Y; Nelson DR; Modave F; Wu Y; Hogan W; Prosperi M; Bian J
    AMIA Annu Symp Proc; 2018; 2018():1601-1610. PubMed ID: 30815206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Piloting the EHR4CR feasibility platform across Europe.
    Doods J; Bache R; McGilchrist M; Daniel C; Dugas M; Fritz F;
    Methods Inf Med; 2014; 53(4):264-8. PubMed ID: 24954881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recruitment of trial participants through electronic medical record patient portal messaging: A pilot study.
    Plante TB; Gleason KT; Miller HN; Charleston J; McArthur K; Himmelfarb CD; Lazo M; Ford DE; Miller ER; Appel LJ; Juraschek SP;
    Clin Trials; 2020 Feb; 17(1):30-38. PubMed ID: 31581836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of a Clinical Trial-Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer.
    Coquet J; Bievre N; Billaut V; Seneviratne M; Magnani CJ; Bozkurt S; Brooks JD; Hernandez-Boussard T
    JAMA Netw Open; 2021 Jan; 4(1):e2031730. PubMed ID: 33481032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electronic health records: new opportunities for clinical research.
    Coorevits P; Sundgren M; Klein GO; Bahr A; Claerhout B; Daniel C; Dugas M; Dupont D; Schmidt A; Singleton P; De Moor G; Kalra D
    J Intern Med; 2013 Dec; 274(6):547-60. PubMed ID: 23952476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secondary use of routinely collected patient data in a clinical trial: an evaluation of the effects on patient recruitment and data acquisition.
    Köpcke F; Kraus S; Scholler A; Nau C; Schüttler J; Prokosch HU; Ganslandt T
    Int J Med Inform; 2013 Mar; 82(3):185-92. PubMed ID: 23266063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developing a new model for patient recruitment in mental health services: a cohort study using Electronic Health Records.
    Callard F; Broadbent M; Denis M; Hotopf M; Soncul M; Wykes T; Lovestone S; Stewart R
    BMJ Open; 2014 Dec; 4(12):e005654. PubMed ID: 25468503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of Eligibility Criteria Relevance for the Purpose of IT-Supported Trial Recruitment: Descriptive Quantitative Analysis.
    Blasini R; Strantz C; Gulden C; Helfer S; Lidke J; Prokosch HU; Sohrabi K; Schneider H
    JMIR Form Res; 2024 Jan; 8():e49347. PubMed ID: 38294862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility pre-screening for pediatric oncology patients.
    Ni Y; Wright J; Perentesis J; Lingren T; Deleger L; Kaiser M; Kohane I; Solti I
    BMC Med Inform Decis Mak; 2015 Apr; 15():28. PubMed ID: 25881112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE.
    Ahmad FS; Ricket IM; Hammill BG; Eskenazi L; Robertson HR; Curtis LH; Dobi CD; Girotra S; Haynes K; Kizer JR; Kripalani S; Roe MT; Roumie CL; Waitman R; Jones WS; Weiner MG
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006292. PubMed ID: 32466729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.
    Filion M; Forget G; Brochu O; Provencher L; Desbiens C; Doyle C; Poirier B; DuRocher M; Camden S; Lemieux J
    Clin Trials; 2012 Oct; 9(5):652-9. PubMed ID: 23060323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deep Learning Approach to Parse Eligibility Criteria in Dietary Supplements Clinical Trials Following OMOP Common Data Model.
    Bompelli A; Li J; Xu Y; Wang N; Wang Y; Adam T; He Z; Zhang R
    AMIA Annu Symp Proc; 2020; 2020():243-252. PubMed ID: 33936396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A method for cohort selection of cardiovascular disease records from an electronic health record system.
    Abrahão MTF; Nobre MRC; Gutierrez MA
    Int J Med Inform; 2017 Jun; 102():138-149. PubMed ID: 28495342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Desiderata for Major Eligibility Criteria in Breast Cancer Clinical Trials.
    Paulson ML; Weng C
    AMIA Annu Symp Proc; 2015; 2015():2025-34. PubMed ID: 26958302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.